Michael C. Mithoefer

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein et al. · Nature Medicine · 2021 · 953 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology · 2010 · 668 citations · Full text

Pharmacy, Psychiatry, Psychology +17

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia et al. · The Lancet Psychiatry · 2018 · 438 citations

Medicine, Psychiatry, Psychology +17

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

Jennifer Mitchell, Marcela Ot’alora G., Bessel van der Kolk et al. · Nature Medicine · 2023 · 387 citations · Full text

Medicine, Psychiatry, Psychology +17

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology · 2012 · 373 citations · Full text

Medicine, Psychiatry, Psychology +17